| Dr Jeffrey H Kerner, MD | |
|
911-913 State Street, New Haven, CT 06511-3926 | |
| (203) 503-3000 | |
| (203) 782-6243 |
| Full Name | Dr Jeffrey H Kerner |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 49 Years |
| Location | 911-913 State Street, New Haven, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609874999 | NPI | - | NPPES |
| 004235900 | Medicaid | CT |
| Entity Name | Connecticut Ear Nose Throat Medical And Surgical Specialists Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699836197 PECOS PAC ID: 6103730700 Enrollment ID: O20031118000400 |
News Archive
Using complex computational algorithms based on repeated sampling, a University of Arkansas graduate student helped spearhead a project to develop a computer simulator that provides customized electron beam tunings for radiation therapy.
Fovea Pharmaceuticals announced today that it has entered into a binding agreement with sanofi-aventis to sell 100% of its share to sanofi-aventis. Fovea has a portfolio of three clinical compounds, a unique technology platform and several discovery programs dedicated to back of the eye diseases.
"The Chinese drug industry is on the verge of getting the green light to manufacture the Japanese encephalitis vaccine for the developing world, an event that will signal the emergence of a major new player in global vaccines," BMJ reports.
CytomX Therapeutics, a biotechnology company focused on the development of proteolytically activated antibodies, today announced the receipt of two grants totaling more than $488,000 from the Qualifying Therapeutic Discovery Project (QTDP) Program. The grants are directed toward the company's lead preclinical programs targeting colon, head and neck, pancreatic and triple-negative breast cancers and glioblastoma multiforme (GBM).
A UC Davis Health pediatric team presented a powerful case series of three teenagers who had unexplained breathing problems during the COVID-19 pandemic.
› Verified 6 days ago
| Entity Name | Robert L Weiss Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174724199 PECOS PAC ID: 6103903034 Enrollment ID: O20080402000770 |
News Archive
Using complex computational algorithms based on repeated sampling, a University of Arkansas graduate student helped spearhead a project to develop a computer simulator that provides customized electron beam tunings for radiation therapy.
Fovea Pharmaceuticals announced today that it has entered into a binding agreement with sanofi-aventis to sell 100% of its share to sanofi-aventis. Fovea has a portfolio of three clinical compounds, a unique technology platform and several discovery programs dedicated to back of the eye diseases.
"The Chinese drug industry is on the verge of getting the green light to manufacture the Japanese encephalitis vaccine for the developing world, an event that will signal the emergence of a major new player in global vaccines," BMJ reports.
CytomX Therapeutics, a biotechnology company focused on the development of proteolytically activated antibodies, today announced the receipt of two grants totaling more than $488,000 from the Qualifying Therapeutic Discovery Project (QTDP) Program. The grants are directed toward the company's lead preclinical programs targeting colon, head and neck, pancreatic and triple-negative breast cancers and glioblastoma multiforme (GBM).
A UC Davis Health pediatric team presented a powerful case series of three teenagers who had unexplained breathing problems during the COVID-19 pandemic.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeffrey H Kerner, MD 400 Columbus Ave, New Haven, CT 06519-1233 Ph: (203) 503-3250 | Dr Jeffrey H Kerner, MD 911-913 State Street, New Haven, CT 06511-3926 Ph: (203) 503-3000 |
News Archive
Using complex computational algorithms based on repeated sampling, a University of Arkansas graduate student helped spearhead a project to develop a computer simulator that provides customized electron beam tunings for radiation therapy.
Fovea Pharmaceuticals announced today that it has entered into a binding agreement with sanofi-aventis to sell 100% of its share to sanofi-aventis. Fovea has a portfolio of three clinical compounds, a unique technology platform and several discovery programs dedicated to back of the eye diseases.
"The Chinese drug industry is on the verge of getting the green light to manufacture the Japanese encephalitis vaccine for the developing world, an event that will signal the emergence of a major new player in global vaccines," BMJ reports.
CytomX Therapeutics, a biotechnology company focused on the development of proteolytically activated antibodies, today announced the receipt of two grants totaling more than $488,000 from the Qualifying Therapeutic Discovery Project (QTDP) Program. The grants are directed toward the company's lead preclinical programs targeting colon, head and neck, pancreatic and triple-negative breast cancers and glioblastoma multiforme (GBM).
A UC Davis Health pediatric team presented a powerful case series of three teenagers who had unexplained breathing problems during the COVID-19 pandemic.
› Verified 6 days ago
Dr. Kiley Edward Trott, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 1 Park Street, Wing West Pavilion Fl 2nd Floor, New Haven, CT 06504 Phone: 203-785-5430 Fax: 203-785-3970 | |
Mark S Bianchi, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 55 Lock Street, New Haven, CT 06511 Phone: 203-375-0050 Fax: 203-380-1616 | |
Dr. Sara Isabel Pai, MD, PHD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 35 Park St, New Haven, CT 06519 Phone: 855-476-4569 | |
Dr. Richard Peter Manes, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 800 Howard Ave Fl 4, Yale Physicians Building, New Haven, CT 06519 Phone: 203-785-2593 Fax: 203-785-3970 | |
Sam D Schild, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 330 Cedar Street, New Haven, CT 06510 Phone: 203-785-5430 | |
Mark A Dagostino, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1 Long Wharf Dr, Suite 302, New Haven, CT 06511 Phone: 203-776-1288 Fax: 203-776-7741 | |
Ken Yanagisawa, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1 Long Wharf Dr, Suite 302, New Haven, CT 06511 Phone: 203-787-4244 Fax: 203-776-7741 |